All stock lists
Unlock the score
Uzin Utz SE (Deutsche Börse:UZU.DE)
DE · Delayed Price · Currency is EUR
Basic Materials · Chemicals - Specialty
67.20-0.40 (-0.59%)
Market cap
$339M
Insider Score
Health Score
Listed since
Nov 19, 1998
Website
Insider Score
/ 100
UZU.DE Insider Score
Uzin Utz SE has a live Insider Score.
Scored on 7 qualifying trades from 1 insider in the last 90 days.
Financial Health Score
Sound
From UZU.DE’s reported statements · Q2 2026 (trailing 12 months)
Profitability13 / 20
Profitable, but on a thin margin.
- Revenue
- $1.01B
- Net income
- $57.9M
- Net margin
- 5.7%
Leverage17 / 20
Little or no net debt.
- Total debt
- $105.8M
- Cash
- $37.9M
- Net debt / EBITDA
- 0.53x
Liquidity15 / 20
Comfortably covers what is due within a year.
- Current assets
- $213.3M
- Current liabilities
- $130.3M
- Current ratio
- 1.64
Cash generation13 / 20
Roughly cash-neutral.
- Operating cash flow
- $73.7M
- Free cash flow
- $36.0M
- FCF margin
- 3.6%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 5.0M
- Share growth (1y)
- -0.2%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
UZU.DE Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | 273.96 M | 253.32 M | 251.75 M | 233.75 M | 242.28 M | 234.67 M |
| Revenue Growth (YoY) | 13.07 % | 7.95 % | 2.90 % | -2.87 % | -1.70 % | 7.42 % |
| Cost of Revenue | 201.31 M | 104.60 M | 101.87 M | 94.96 M | 102.68 M | 178.32 M |
| Gross Profit | 72.65 M | 148.73 M | 149.88 M | 138.79 M | 139.61 M | 56.35 M |
| SG&A Expense | 54.83 M | 49.91 M | 68.56 M | 77.03 M | 64.83 M | -17.18 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.65 M |
| Operating Expenses | 51.98 M | 129.40 M | 129.44 M | 115.84 M | 119.75 M | -2.95 M |
| Operating Income | 20.67 M | 19.33 M | 20.44 M | 22.95 M | 19.86 M | 59.30 M |
| Pretax Income | 18.91 M | 18.37 M | 18.71 M | 22.42 M | 17.34 M | 15.55 M |
| Tax Provision | 4.50 M | 5.86 M | 4.74 M | 5.27 M | 5.00 M | 3.98 M |
| Net Income | 14.39 M | 12.50 M | 13.95 M | 17.06 M | 12.38 M | 11.56 M |
| EPS (Basic) | 2.85 | 2.47 | 2.77 | 3.39 | 2.45 | 2.29 |
| EPS (Diluted) | 2.85 | 2.47 | 2.77 | 3.39 | 2.45 | 2.29 |
| Shares Outstanding | 5.04 M | 5.04 M | 5.04 M | 5.04 M | 5.05 M | 5.05 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.